Demant AS

DEMANT: XCSE (DNK)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
DKK 453.00ZndkxzPdpghlxh

Demant's Interim Results Show Strong Hearing Healthcare Recovery

We anticipate moderately increasing our fair value estimate for narrow-moat Demant following management’s interim statement. Management increased its fiscal 2021 EBIT outlook to DKK 3,300 million-3,500 million from DKK 3,150 million-3,450 million on the strength of the hearing business. We currently view the shares as modestly overvalued.

Sponsor Center